VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$3.0400
+0.0100 ( -4.70% ) 300.7K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$3.0400
Previous close
$3.0300
Volume
300.7K
Market cap
$84.37M
Day range
$2.9450 - $3.2700
52 week range
$2.2200 - $5.8300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Jun 28, 2024 |
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 4 | Insider transactions | 1 | Jun 26, 2024 |
| 10-k | Annual reports | 82 | Jun 11, 2024 |
| 8-k | 8K-related | 15 | Jun 11, 2024 |
| 8-k | 8K-related | 14 | May 31, 2024 |
| 8-k | 8K-related | 16 | May 24, 2024 |
| 8-k | 8K-related | 17 | Apr 26, 2024 |